PRAGUE-18 Study Ticagrelor versus Prasugrel
from ujanssens
More from this publisher
30.08.2016
Views
Study aims 1. „Head-to-head“ comparison of prasugrel vs. ticagrelor in STEMI treated by p-PCI 2. Safety of (economically motivated) postdischarge switch from prasu/tica to clopidogrel.
- Page 1: PRAGUE-18 Study: Randomized compari
- Page 5 and 6: Methods • Randomization immediate
- Page 7 and 8: Primary end-point (7 days)
- Page 9: Conclusions The study did not show
<strong>Study</strong> aims<br />
1. „Head-to-head“ comparison of prasugrel vs.<br />
ticagrelor in STEMI treated by p-PCI<br />
2. Safety of (economically motivated) postdischarge<br />
switch from prasu/tica to<br />
clopidogrel.
Change language